These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8421413)
1. Serologic determinants of survival in patients with head and neck cancer: validating a clinical prediction model. Lydiatt DD; Savage HE; Clayman GL; Liu FJ; Sample D; Schantz SP Laryngoscope; 1993 Jan; 103(1 Pt 1):13-6. PubMed ID: 8421413 [TBL] [Abstract][Full Text] [Related]
2. Significance of C1q-binding macromolecules within the head and neck cancer patient. Schantz SP; Savage HE; Brown BW; Young G; Liu FJ; Reger G; Newman RA Cancer Res; 1990 Jul; 50(14):4349-54. PubMed ID: 2364389 [TBL] [Abstract][Full Text] [Related]
3. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Doweck I; Denys D; Robbins KT Laryngoscope; 2002 Oct; 112(10):1742-9. PubMed ID: 12368607 [TBL] [Abstract][Full Text] [Related]
4. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309 [TBL] [Abstract][Full Text] [Related]
6. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695 [TBL] [Abstract][Full Text] [Related]
7. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma. Heimdal JH; Aarstad HJ; Olofsson J Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427 [TBL] [Abstract][Full Text] [Related]
8. Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma. Preuss SF; Klussmann JP; Wittekindt C; Damm M; Semrau R; Drebber U; Guntinas-Lichius O Eur J Surg Oncol; 2007 Apr; 33(3):358-63. PubMed ID: 17157472 [TBL] [Abstract][Full Text] [Related]
10. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Layland MK; Sessions DG; Lenox J Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872 [TBL] [Abstract][Full Text] [Related]
11. Plasma osteopontin is an independent prognostic marker for head and neck cancers. Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy. Dietl B; Marienhagen J; Schäfer C; Kölbl O Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968 [TBL] [Abstract][Full Text] [Related]
13. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue]. Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277 [TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of head and neck cancer with retinoids: a negative result. Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma. Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295 [TBL] [Abstract][Full Text] [Related]
17. Analysis of treatment results for base of tongue cancer. Sessions DG; Lenox J; Spector GJ; Chao C; Chaudry OA Laryngoscope; 2003 Jul; 113(7):1252-61. PubMed ID: 12838028 [TBL] [Abstract][Full Text] [Related]
18. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542 [TBL] [Abstract][Full Text] [Related]
19. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]